RSV Vaccines Are Coming At Last: Your Health,...

In this episode of Science Quickly, host Rachel Feltman and Scientific American senior desk editor for health and medicine Tanya Lewis break down the fast-growing Ebola outbreak—caused by a viral species with no approved vaccine—in the Democratic Republic of the Congo and Uganda. ...  Show more

In this episode of Science Quickly, author Vanessa Chang discusses her book The Body Digital: A Brief History of Humans and Machines from Cuckoo Clocks to ChatGPT. The book explores how technologies—from handwriting to smartphones and AI—don’t just extend human capability but sub ...  Show more

Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messag ...  Show more

A recent vaccine trial from Oxford University shows promising preliminary results, suggesting the vaccine can produce immune responses that may protect people against infection. Dr. Sanjay Gupta spoke with Dr. Barney Graham, the deputy director of the Vaccine Research Center at t ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

Protection from serious infant illnesses isn’t enough. Helping prevent the disease from happening altogether is the goal of physician-scientists, like Dr. Bill Gruber. As the Senior Vice President of Pfizer Vaccine Clinical Research and Development, Bill explains how maternal vac ...  Show more